References
Elsayed E, Elarabi MA, Sherif DA, Elmorshedi M, El-Mashad N. Extensive drug resistant Acinetobacter baumannii: a comparative study between non-colistin based combinations. Int J Clin Pharm. 2020;42(1):80–8.
Garnacho-Montero J, Timsit J-F. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. 2019;32(1):69–76.
Idelevich EA, Freeborn DA, Seifert H, Becker K. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2018;91(4):360–2.
Ni W, Han Y, Zhao J, Wei C, Cui J, Wang R, Liu Y. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;47(2):107–16.
Martín-Aspas A, Guerrero-Sánchez FM, García-Colchero F, Rodríguez-Roca S, Girón-González JA. Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist. 2018;11:861–72.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None declared.
Ethics approval
Not required.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Savary, R., Taghizadeh-Ghehi, M., Kohneloo, A.J. et al. A comparative study between non‑colistin based combinations for treatment of infections caused by extensive drug resistant Acinetobacter baumannii: comments. Int J Clin Pharm 43, 768–769 (2021). https://doi.org/10.1007/s11096-020-01208-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-020-01208-9